Abstract
Adenosine is known to be associated with effects such as inhibition of immune response, coronary vasodilation, stimulation of angiogenesis, and inhibition of inflammatory reactions. Some authors suggest that adenosine may also have similar functions in tumor tissues. Tissue levels of adenosine are under close regulation by different enzymes acting at different levels. Adenosine is produced from AMP by the action of 5′-nucleotidase (5′-NT) and is converted back into AMP by adenosine kinase (AK) or into inosine by adenosine deaminase (ADA). Inosine is converted into purine catabolites by purine nucleoside phosphorylase (PNP), whereas AMP is converted into ADP and ATP by adenylate kinase (MK).
The aim of this study was to analyze the activities of the above enzymes in fragments of neoplastic and apparently normal mucosa, obtained less than 5 cm and at least 10 cm from tumors, in 40 patients with colorectal cancer.
The results showed much higher activities of ADA, AK, 5′-NT, and PNP in tumor tissue than in neighboring mucosa (p>0.01 for ADA, AK, and PNP; p>0.05 for 5′-NT), suggesting that the activities of purine metabolizing enzymes increase to cope with accelerated purine metabolism in cancerous tissue. The simultaneous increase in ADA and 5′-NT activities might be a physiological attempt by cancer cells to provide more substrate to accelerate salvage pathway activity.
References
Arch JR, Newsholme E.A. Activities and some properties of 5′-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine. Biochem J 1978; 174:965–977.
Spychala J, Mitchell BS, Barankiewicz J. Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell differentiation. J Immunol 1997; 158:4947–4952.
Spychala J. Tumour-promoting function of adenosine. Pharmacol Therapy 2000; 87:161–173.
Bontemps F, Vincent MF, Van den Berghe G. Mechanism of elevation of adenosine levels in anoxic hepatocytes. Biochem J 1993, 290:671–677.
Meghji P, Middleton KM, Newby AC. Absolute rates of adenosine formation during ischaemia in rat and pigeon hearts. Biochem J 1988; 249:695–703.
Hockel M, Vaupel P. Tumour hypoxia: definitions and current clinical, biologic and molecular aspects. J Natl Cancer Inst 2001, 93:266–276.
Moriwaki Y, Yamamoto T, Higashino K. Enzymes involved in purine metabolism: a review of histochemical localization and functional implications. Histol Histopathol 1999; 14:1321–1340.
Bianchi V, Spychala J. Mammalian 5′-nucleotidase. J Biol Chem 2003; 278:46195–46198.
Lehto MT, Sharom FJ. Release of the glycosylphosphatidylinositol-anchored enzyme ecto-5′ nucleotidase by phospholipase C: catalytic activation and modulation by the lipid bilayer. Biochem J 1998; 332:101–109.
Kowaluk EA, Bhagwat SS, Jarvis MF. Adenosine kinase inhibitors. Curr Pharmacol Des 1998; 4:403–416.
Yamada Y, Goto H, Ogasawara N. Purification and properties of adenosine kinase from rat brain. Biochim Biophys Acta 1980; 616:199–207.
Hirschhorn R, Yang DR, Israni A. An asp8-to-asm substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA2 allozyme): occurrence in different chromosomal backgrounds and apparent intragenic crossover. Ann Hum Genet 1994; 58:1–9.
Rubio R, Berne RM. Localization of purine and pyrimidine nucleoside phosphorylases in heart, kidney and liver. Am J Physiol 1980; 239:H721–730.
Rao PN, et al. Purine nucleoside phosphorylase: a new marker for free oxygen radical injury to the endothelial cell. Hepatology 1990; 11:193–198.
Minor TH, et al. Determination of plasma activities of purine phosphorylase by high-performance liquid chromatography: estimates of non parenchyma cell injury after porcine liver transplantation. J Chromatogr B 1995; 670:332–336.
Zeleznikar RJ, et al. Evidence for compartmentalized adenylate kinase catalysis serving a high energy phosphoryl transfer function in rat skeletal muscle J Biol Chem 1990; 265:300–311.
Matsuura S, et al. Human adenylate kinase deficiency associated with hemolytic anemia. J Biol Chem 1989; 264:10148–10152.
Eroglu A, et al. Activities of adenosine deaminase and 5′-nucleotidase in cancerous and noncancerous human colorectal tissues. Med Oncol 2000, 17:319–324.
Majer J, Horbov S, Nygaard P. Purine metabolizing enzymes in lymphocytes from patients with solid tumours. Acta Med Scand 1984; 215:5–11.
Canbolat O, et al. Activities of adenosine deaminase, 5′-nucleotidase, guanase and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Canc Res Treat 1996; 37:189–193.
Durak I, et al. Activity of the enzymes participating in purine metabolism of cancerous and non-cancerous human kidney tissues. Cancer Invest 1997; 15:212–216.
Biri H, et al. Activities of DNA turnover and free radical metabolizing enzymes in cancerous human prostate tissue. Cancer Invest 1999; 17:314–319.
Natsumeda Y, Prajda N, Donohue JP; Glover JL, Weber G. Enzymic capacities of purine de novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues. Cancer Res 1984; 44:2475–2479.
Natsumeda Y, et al. Purine enzymology of human colon carcinomas. Cancer Res 1985; 45:2556–2559.
Wei S, et al. Purine metabolism in two human melanoma cell lines: relation to proliferation and differentiation. Melanoma Res 1999; 9:351–359.
Rendekova V, et al. Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral blood cells of patients with neoplastic diseases in bronchogenic carcinoma. Neoplasma 1983; 30:233–238.
Harris NL, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international Lymphoma Study Group. Blood 1994; 84:1361–1392.
Weber G. Enzymes of purine metabolism in cancer. Clin Biochem 1983; 16:57–73.
Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248–254.
Lin HY, Fox IH, Spychala J. ATP degradation and depletion of adenine nucleotides. In: Zelenock GB (ed). Clinical Ischemic Syndromes. Mechanism and Consequences of Tissue Injury. The C.V. Mosby Company: St. Louis, MO, 1990, pp. 159–186.
Camici M, et al. Purine salvage enzyme activities in normal and neoplastic human tissues. Cancer Biochem Biophys 1990; 11:201–209.
Sanfilippo O, et al. Relationship between the levels of purine salvage pathway enzymes and clinical biological aggressiveness of human colon carcinoma. Cancer Biochem Biophys 1994; 14:57–66.
Carlucci F, et al. Purine nucleotide metabolism: specific aspects in chronic lymphocytic leucemia lymphocytes. Biochim Biophys Acta 1997; 1360:203–210.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vannoni, D., Bernini, A., Carlucci, F. et al. Enzyme activities controlling adenosine levels in normal and neoplastic tissues. Med Oncol 21, 187–195 (2004). https://doi.org/10.1385/MO:21:2:187
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MO:21:2:187